Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Clinical trial NCT05007093 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05007093
- Sponsor
- Yansong Lin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2024-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.